+ Translate
+ Most Popular
Gaucher's disease;thirty-two years experience at Siriraj Hospital
A study of Macrobathra Meyrick from China (Lepidoptera, Cosmopterigidae)
First occurrence in ores of tetragonal chalcocite
Effects of trace element nutrition on sleep patterns in adult women
N.Z. range management guidelines. 2. Design of grazing management systems for tussock country
A case of lipoma of the esophagus
A revision of world Acanthosomatidae (Heteroptera: Pentatomidae): keys to and descriptions of subfamilies, tribes and genera, with designation of types
Life history of the coronate scyphozoan Linuche unguiculata (Swartz, 1788)
Perceptual restoration of obliterated sounds
Mutagenicity studies on two chromium(III) coordination compounds
The formation of the skeleton. I. Growth of a long bone. 1st appearance of a center of calcification
Leucopenia and abnormal liver function in travellers on malaria chemoprophylaxis
The joint commission: four key root causes loom large in sentinel event data
Treatment of vitiligo with topical 15% lactic acid solution in combination with ultra violet-A
Behaviour of dairy cows within three hours after feed supply: I. Influence of housing type and time elapsing after feed supply
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Management and control of patients with type 2 diabetes mellitus in Lebanon: results from the International Diabetes Management Practices Study (IDMPS)
The diet composition and nutritional knowledge of patients with anorexia nervosa
Physoporella croatica Herak, 1958 of the Slovak karst Anisian (Slovakia, the West Carpathians Mts.)
Bright lights, big noise. How effective are vehicle warning systems?
Ein Plesiosaurier-Rest mit Magensteinen aus mittlerem Lias von Quedlinburg
Incidence of Chlamydia trachomatis in patients with sterility
Monster soup: the microscope and Victorian fantasy
Preliminary tests with residual sprays against poultry lice
Duration of the life of plants in phylogeny

Pharmaco-economics of levosimendan in cardiology: a European perspective

Pharmaco-economics of levosimendan in cardiology: a European perspective

International Journal of Cardiology 199: 337-341

ISSN/ISBN: 0167-5273

PMID: 26241640

DOI: 10.1016/j.ijcard.2015.07.049

Heart failure places a significant economic burden on health care. Acute heart failure requires hospitalization and often frequent re-hospitalization in expensive wards where vasoactive rescue therapy is often added on top of standard medications. In these lean times, there is a growing need for cost-effective therapeutic options that supply superior support and in addition shorten the length of stay in hospital and reduce re-hospitalization rates. The inodilator levosimendan represents the latest addition to the vasoactive treatments of acute heart failure patients, and it appears to meet these expectations. Our aim was to answer the question whether the treatment efficacy of levosimendan - when selected as therapy for patients hospitalized for acute heart failure - brings savings to hospitals in various European countries representing different economies. We took a conservative approach and selected some a fortiori arguments to simplify the calculations. We selected seven European countries to represent different economies: Italy, Spain, Greece, Germany, Sweden, Finland and Israel. Data on the costs of medications and on the cost per day were collected and fed in a simple algorithm to detect savings. These saving varied from country to country, from a minimum of €0.50 in Germany to a maximum of €354.64 in Sweden. The use of levosimendan as a therapy for patients hospitalized for acute heart failure provides a net saving to hospitals driven by a reduction in the length of hospital stay. This finding is true in each of the countries considered in this study.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058538136

Download citation: RISBibTeXText

Related references

Master of Science in cardiovascular health economics launched by European Society of Cardiology and London School of Economics. European heart journal 35(47): 3317-3318, 2014

Continuing medical education in cardiology: the ESC perspective. European Society of Cardiology. European Heart Journal 21(3): 182-184, 2000

Aspects pharmaco-économiques de l'antibiothérapie à l'hôpital - Pharmaco-economics and antibiotherapy in the hospital. Rmlg. Revue Medicale de Liege 53(5): 279-284, 1998

Women in cardiology: a European perspective. Heart 91(3): 275-276, 2005

Nuclear cardiology: a European perspective. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 5(5): 538-541, 1998

Cardiology in Poland - a European perspective. Kardiologia Polska 72(2): 116-121, 2014

New devices in interventional cardiology: a European perspective. Australian and New Zealand Journal of Medicine 25(2): 162-168, 1995

Recommendations of the European Board for the Specialty Cardiology (EBSC) for education and training in basic cardiology in Europe. The Executive Committee of the European Board for the Specialty Cardiology. European Heart Journal 17(7): 996-1000, 1996

Interventional cardiology. Monitoring catheter ablation of AF--the European perspective. Nature Reviews. Cardiology 11(5): 251-252, 2014

Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. European heart journal 29(4): 531-556, 2008

The economics of horticultural therapy: a European perspective. Acta Horticulturae 639: 179-183, 2004

Telemonitoring in the Management of Chronic Heart Failure: The European Society of Cardiology Perspective. Disease Management and Health Outcomes 14(1 Suppl): 1-2, 2006

Economics of cereal disease control - a European perspective. The BCPC Conference: Pests and diseases, Volume 2 Proceedings of an international conference held at the Brighton Hilton Metropole Hotel, Brighton, UK, 13-16 November 2000: 639-646, 2000

Intérêt de la pharmaco-économie : Le point de vue de l'industrie pharmaceutique - Pharmaco-economics : The view point of the pharmaceutical industry. Rmlg. Revue Medicale de Liege 53(5): 236-241, 1998

Economics and attitudes regarding spectacles in daily life: a European perspective. Ophthalmic Epidemiology 16(4): 218-223, 2009